Synchrony Financial's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Synchrony Financial reported net income of $3.6B (+1.5% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Interest and fees on loans (Note 5) | $21.7B | $21.6B | $19.9B | $16.9B |
| Interest on cash and debt securities | $903.0M | $1.0B | $808.0M | $265.0M |
| Total interest income | $22.6B | $22.6B | $20.7B | $17.1B |
| Interest on deposits | $3.3B | $3.8B | $3.0B | $1.0B |
| Interest on borrowings of consolidated securitization entities | $417.0M | $427.0M | $340.0M | $196.0M |
| Interest on senior and subordinated unsecured notes | $388.0M | $401.0M | — | — |
| Total interest expense | $4.1B | $4.6B | $3.7B | $1.5B |
| Net interest income | $18.5B | $18.0B | $17.0B | $15.6B |
| Retailer share arrangements | ($4.0B) | ($3.4B) | ($3.7B) | ($4.3B) |
| Provision for credit losses (Note 5) | $5.2B | $6.7B | $6.0B | $3.4B |
| Net interest income, after retailer share arrangements and provision for credit losses | $9.2B | $7.9B | $7.4B | $7.9B |
| Interchange revenue | $1.1B | $1.0B | $1.0B | $982.0M |
| Protection product revenue | $596.0M | $562.0M | $510.0M | — |
| Loyalty programs | ($1.4B) | ($1.4B) | ($1.4B) | ($1.3B) |
| Other | $295.0M | $1.3B | $118.0M | $268.0M |
| Total other income | $520.0M | $1.5B | $289.0M | $380.0M |
| Employee costs | $2.1B | $1.9B | $1.9B | $1.7B |
| Professional fees | $936.0M | $936.0M | $842.0M | $832.0M |
| Marketing and business development | $511.0M | $524.0M | $527.0M | $487.0M |
| Information processing | $899.0M | $803.0M | $712.0M | $623.0M |
| Other | $696.0M | $704.0M | $793.0M | $714.0M |
| Total other expense | $5.1B | $4.8B | $4.8B | $4.3B |
| Earnings before provision for income taxes | $4.6B | $4.6B | $2.9B | $4.0B |
| Provision for income taxes (Note 15) | $1.1B | $1.1B | $666.0M | $946.0M |
| Net earnings | $3.6B | $3.5B | $2.2B | $3.0B |
| Net earnings available to common stockholders | $3.5B | $3.4B | $2.2B | $3.0B |
| Basic (in usd per share) | $9.38 | $8.64 | $5.21 | $6.19 |
| Diluted (in usd per share) | $9.28 | $8.55 | $5.19 | $6.15 |
| Line item | Sep 30, 2026 · Q3 | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 |
|---|---|---|---|---|
| Interest and fees on loans (Note 4) | $5.6B | $5.4B | $5.4B | $5.5B |
| Interest on cash and debt securities | $197.0M | $203.0M | $190.0M | $221.0M |
| Total interest income | $5.8B | $5.6B | $5.6B | $5.7B |
| Interest on deposits | $767.0M | $767.0M | $770.0M | $812.0M |
| Interest on senior and subordinated unsecured notes | $106.0M | $97.0M | $92.0M | $94.0M |
| Interest on borrowings of consolidated securitization entities | $106.0M | $111.0M | $106.0M | $105.0M |
| Total interest expense | $979.0M | $975.0M | $968.0M | $1.0B |
| Net interest income | $4.8B | $4.6B | $4.6B | $4.7B |
| Retailer share arrangements | ($1.1B) | ($1.0B) | ($1.1B) | ($1.0B) |
| Provision for credit losses (Note 4) | $1.3B | $1.2B | $1.3B | $1.1B |
| Net interest income, after retailer share arrangements and provision for credit losses | $2.4B | $2.4B | $2.2B | $2.5B |
| Interchange revenue | $302.0M | $300.0M | $264.0M | $272.0M |
| Protection product revenue | $168.0M | $161.0M | $161.0M | $149.0M |
| Loyalty programs | ($439.0M) | ($436.0M) | ($361.0M) | ($368.0M) |
| Other | $74.0M | $112.0M | $69.0M | $74.0M |
| Total other income | $105.0M | $137.0M | $133.0M | $127.0M |
| Employee costs | $507.0M | $516.0M | $515.0M | $503.0M |
| Professional fees | $234.0M | $220.0M | $209.0M | $240.0M |
| Marketing and business development | $137.0M | $137.0M | $114.0M | $120.0M |
| Information processing | $260.0M | $248.0M | $262.0M | $226.0M |
| Other | $233.0M | $210.0M | $216.0M | $159.0M |
| Total other expense | $1.4B | $1.3B | $1.3B | $1.2B |
| Earnings before provision for income taxes | $1.2B | $1.2B | $1.0B | $1.4B |
| Provision for income taxes (Note 13) | $289.0M | $301.0M | $242.0M | $352.0M |
| Net earnings | $892.0M | $885.0M | $805.0M | $1.1B |
| Net earnings available to common stockholders | $864.0M | $864.0M | $784.0M | $1.1B |
| Basic (in usd per share) | $2.71 | $2.61 | $2.29 | $2.89 |
| Diluted (in usd per share) | $2.68 | $2.59 | $2.27 | $2.86 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and equivalents | $15.0B | $14.7B | $14.3B | $10.3B |
| Debt securities | $2.3B | $3.1B | $3.8B | $4.9B |
| Total loan receivables | $103.8B | $104.7B | $103.0B | $92.5B |
| Less: Allowance for credit losses | ($10.4B) | ($10.9B) | ($10.6B) | ($9.5B) |
| Loan receivables, net | $93.4B | $93.8B | $92.4B | $82.9B |
| Goodwill | $1.4B | $1.3B | $1.0B | $1.1B |
| Intangible assets, net (Note 7) | $1.3B | $854.0M | $815.0M | $1.3B |
| Other assets | $5.8B | $5.8B | $4.9B | $4.1B |
| Total assets | $119.1B | $119.5B | $117.5B | $104.6B |
| Interest-bearing deposit accounts | $80.7B | $81.7B | $80.8B | $71.3B |
| Non-interest-bearing deposit accounts | $396.0M | $398.0M | $364.0M | $399.0M |
| Total deposits | $81.1B | $82.1B | $81.2B | $71.7B |
| Borrowings of consolidated securitization entities | $8.4B | $7.8B | $7.3B | $6.2B |
| Senior and subordinated unsecured notes | $6.8B | $7.6B | $8.7B | $8.0B |
| Total borrowings | $15.2B | $15.5B | $16.0B | $14.2B |
| Accrued expenses and other liabilities | $6.0B | $5.4B | $6.3B | $5.8B |
| Total liabilities | $102.3B | $102.9B | $103.6B | $91.7B |
| Preferred stock, par value $0.001 per share; 300 million shares authorized, 1.25 million shares issued and outstanding at December 31, 2025 and December 31, 2024 | $1222000000.00 | $1222000000.00 | $734000000.00 | $734000000.00 |
| Common stock, par value $0.001 per share; 4.0 billion shares authorized; 834 million shares issued at both December 31, 2025 and 2024; 347 million and 388 million shares outstanding at December 31, 2025 and 2024, respectively | $1000000.00 | $1000000.00 | $1000000.00 | $1000000.00 |
| Additional paid-in capital | $9.9B | $9.9B | $9.8B | $9.7B |
| Retained earnings | $24.6B | $21.6B | $18.7B | $16.7B |
| Debt securities | ($6.0M) | ($23.0M) | ($33.0M) | ($93.0M) |
| Currency translation adjustments | ($50.0M) | ($44.0M) | ($38.0M) | ($38.0M) |
| Employee benefit plans and other | $8.0M | $8.0M | $3.0M | $6.0M |
| Treasury stock, at cost; 487 million and 446 million shares at December 31, 2025 and 2024, respectively | -18.9B | -16.1B | -15.2B | -14.2B |
| Total equity | $16.8B | $16.6B | $13.9B | $12.9B |
| Total liabilities and equity | $119.1B | $119.5B | $117.5B | $104.6B |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 |
|---|---|---|---|---|
| Cash and equivalents | $15.9B | $16.2B | $20.6B | $16.2B |
| Debt securities (Note 3) | $4.4B | $4.4B | $3.0B | $2.7B |
| Total loan receivables | $103.3B | $102.2B | $100.1B | $100.2B |
| Less: Allowance for credit losses | ($10.3B) | ($10.3B) | ($10.4B) | ($10.4B) |
| Loan receivables, net | $93.0B | $91.9B | $89.7B | $89.8B |
| Goodwill | $1.4B | $1.4B | $1.4B | $1.3B |
| Intangible assets, net | $147.0M | $152.0M | $1.2B | $909.0M |
| Other assets (Note 6) | $7.7B | $8.0B | $5.7B | $5.8B |
| Total assets | $122.5B | $121.9B | $121.5B | $117.0B |
| Interest-bearing deposit accounts | $82.5B | $82.4B | $82.5B | $79.5B |
| Non-interest-bearing deposit accounts | $438.0M | $430.0M | $416.0M | $373.0M |
| Total deposits | $83.0B | $82.8B | $82.9B | $79.9B |
| Borrowings of consolidated securitization entities | $8.9B | $8.9B | $8.9B | $7.7B |
| Senior and subordinated unsecured notes | $8.1B | $7.5B | $7.5B | $6.8B |
| Total borrowings | $17.0B | $16.4B | $16.4B | $14.4B |
| Accrued expenses and other liabilities | $5.9B | $5.8B | $5.7B | $5.6B |
| Total liabilities | $105.9B | $105.0B | $105.0B | $99.9B |
| Preferred stock, par value $0.001 per share; 300 million shares authorized, 1.26 million and 1.25 million shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively (Note 12) | $1716000000.00 | $1716000000.00 | $1222000000.00 | $1222000000.00 |
| Common stock, par value $0.001 per share; 4.0 billion shares authorized; 834 million shares issued at both September 30, 2026 and December 31, 2025; 311 million and 347 million shares outstanding at September 30, 2026 and December 31, 2025, respectively | $1000000.00 | $1000000.00 | $1000000.00 | $1000000.00 |
| Additional paid-in capital | $9.9B | $9.9B | $9.8B | $9.9B |
| Retained earnings | $26.7B | $26.0B | $25.2B | $24.0B |
| Debt securities | ($44.0M) | ($21.0M) | ($12.0M) | ($8.0M) |
| Currency translation adjustments | ($60.0M) | ($57.0M) | ($52.0M) | ($45.0M) |
| Employee benefit plans and other | $6.0M | $7.0M | $8.0M | $7.0M |
| Treasury stock, at cost; 523 million and 487 million shares at September 30, 2026 and December 31, 2025, respectively | -21.7B | -20.6B | -19.7B | -18.0B |
| Total equity | $16.6B | $16.9B | $16.5B | $17.1B |
| Total liabilities and equity | $122.5B | $121.9B | $121.5B | $117.0B |
| Preferred stock outstanding (in shares) | 1.3M | 1.3M | — | — |
| Preferred stock issued (in shares) | 1.3M | 1.3M | — | — |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net earnings | $3.6B | $3.5B | $2.2B | $3.0B |
| Provision for credit losses | $5.2B | $6.7B | $6.0B | $3.4B |
| Deferred income taxes | $184.0M | ($98.0M) | ($458.0M) | ($421.0M) |
| Depreciation and amortization | $514.0M | $481.0M | $458.0M | $419.0M |
| (Increase) decrease in interest and fees receivable | ($598.0M) | $33.0M | ($645.0M) | ($197.0M) |
| (Increase) decrease in other assets | $123.0M | ($117.0M) | $7.0M | $21.0M |
| Increase (decrease) in accrued expenses and other liabilities | $314.0M | ($121.0M) | $293.0M | ($93.0M) |
| Gain on sale of business | $0 | ($1.1B) | — | — |
| All other operating activities | $537.0M | $507.0M | $735.0M | $574.0M |
| Cash provided from (used for) operating activities | $9.9B | $9.8B | $8.6B | $6.7B |
| Maturity and sales of debt securities | $2.0B | $3.6B | $5.0B | $4.0B |
| Purchases of debt securities | ($1.2B) | ($2.8B) | ($3.6B) | ($3.9B) |
| Acquisitions, net of cash acquired | ($161.0M) | ($1.9B) | — | — |
| Proceeds from sale of business, net of cash and restricted cash sold | $0 | $491.0M | — | — |
| Net (increase) decrease in loan receivables, including held for sale | ($4.6B) | ($7.6B) | ($14.9B) | ($13.7B) |
| All other investing activities | ($852.0M) | ($688.0M) | ($722.0M) | ($549.0M) |
| Cash provided from (used for) investing activities | ($4.9B) | ($8.9B) | ($14.2B) | ($10.2B) |
| Proceeds from issuance of securitized debt | $2.2B | $1.7B | $2.3B | $2.7B |
| Maturities and repayment of securitized debt | ($1.7B) | ($1.1B) | ($1.3B) | ($3.8B) |
| Proceeds from issuance of senior and subordinated unsecured notes | $1.8B | $745.0M | $740.0M | $2.2B |
| Maturities and repayment of senior and subordinated unsecured notes | ($2.6B) | ($1.9B) | $0 | ($1.5B) |
| Proceeds from issuance of preferred stock | $0 | $488.0M | — | — |
| Dividends paid on preferred stock | ($83.0M) | ($72.0M) | ($42.0M) | ($42.0M) |
| Net increase (decrease) in deposits | ($926.0M) | $879.0M | $9.4B | $9.5B |
| Purchases of treasury stock | ($2.9B) | ($1.0B) | ($1.1B) | ($3.3B) |
| Dividends paid on common stock | ($427.0M) | ($398.0M) | ($406.0M) | ($434.0M) |
| All other financing activities | ($63.0M) | $36.0M | ($22.0M) | ($44.0M) |
| Cash provided from (used for) financing activities | ($4.7B) | ($611.0M) | $9.6B | $5.3B |
| Increase (decrease) in cash and equivalents, including restricted and held for sale amounts | $262.0M | $334.0M | $4.0B | $1.7B |
| Cash and equivalents, including restricted amounts, at beginning of year | $14.8B | $14.4B | $10.4B | $8.7B |
| Total cash and equivalents, including restricted and held for sale amounts, at end of year | $2.5B | $2.7B | $3.2B | — |
| Cash and equivalents | $15.0B | $14.7B | $14.3B | $10.3B |
| Restricted cash and equivalents included in other assets | $44.0M | $44.0M | $50.0M | $136.0M |
| Cash and equivalents, including restricted amounts, held for sale | $0 | $0 | $112.0M | — |
| Total cash and equivalents, including restricted and held for sale amounts, at end of year | $15.0B | $14.8B | $14.4B | — |
| Cash paid during the year for interest | ($4.2B) | ($4.7B) | ($3.6B) | ($1.4B) |
| Line item | Sep 30, 2026 · YTD | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD |
|---|---|---|---|---|
| Net earnings | $2.6B | $1.7B | $805.0M | $2.8B |
| Provision for credit losses | $3.8B | $2.5B | $1.3B | $3.8B |
| Deferred income taxes | ($10.0M) | $34.0M | $28.0M | $171.0M |
| Depreciation and amortization | $438.0M | $288.0M | $143.0M | $375.0M |
| All other operating activities | $607.0M | $378.0M | $206.0M | $358.0M |
| (Increase) decrease in interest and fees receivable | ($478.0M) | ($238.0M) | ($124.0M) | ($271.0M) |
| (Increase) decrease in other assets | $150.0M | $37.0M | $102.0M | $114.0M |
| Increase (decrease) in accrued expenses and other liabilities | $10.0M | ($122.0M) | ($312.0M) | $66.0M |
| Cash provided from (used for) operating activities | $7.1B | $4.6B | $2.2B | $7.4B |
| Maturity and sales of debt securities | $2.0B | $855.0M | $500.0M | $1.6B |
| Purchases of debt securities | ($4.0B) | ($2.9B) | ($1.2B) | ($1.2B) |
| Acquisition of loan receivables | ($809.0M) | ($809.0M) | — | — |
| Net (increase) decrease in loan receivables, including held for sale | ($2.8B) | ($436.0M) | $2.4B | $183.0M |
| All other investing activities | ($610.0M) | ($388.0M) | ($144.0M) | ($789.0M) |
| Cash provided from (used for) investing activities | ($6.2B) | ($3.7B) | $1.5B | ($212.0M) |
| Proceeds from issuance of securitized debt | $1.5B | $498.0M | $498.0M | $1.5B |
| Maturities and repayment of securitized debt | ($1.0B) | $0 | $0 | ($1.7B) |
| Proceeds from issuance of senior and subordinated unsecured notes | $1.8B | $745.0M | $745.0M | $1.8B |
| Maturities and repayment of senior and subordinated unsecured notes | ($500.0M) | $0 | $0 | ($2.6B) |
| Dividends paid on preferred stock | ($70.0M) | ($42.0M) | ($21.0M) | ($62.0M) |
| Proceeds from issuance of preferred stock | $494.0M | $494.0M | — | $0 |
| Net increase (decrease) in deposits | $1.8B | $1.7B | $1.7B | ($2.2B) |
| Purchases of treasury stock | ($2.9B) | ($1.8B) | ($900.0M) | ($2.0B) |
| Dividends paid on common stock | ($314.0M) | ($204.0M) | ($104.0M) | ($321.0M) |
| All other financing activities | ($89.0M) | ($89.0M) | ($87.0M) | ($67.0M) |
| Cash provided from (used for) financing activities | $777.0M | $1.3B | $1.9B | ($5.7B) |
| Increase (decrease) in cash and equivalents, including restricted amounts | $1.7B | $2.2B | $5.6B | $1.5B |
| Cash and equivalents, including restricted amounts, at beginning of period | $15.0B | $15.0B | $15.0B | $14.8B |
| Cash and equivalents | $15.9B | $16.2B | $20.6B | $16.2B |
| Restricted cash and equivalents included in other assets | $796.0M | $1.0B | $44.0M | $42.0M |
| Total cash and equivalents, including restricted amounts, at end of period | $16.7B | $17.2B | $20.6B | $16.3B |
Synchrony Financial score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.